It is a private company, called CNA. All tests have been on Caucasians but a multi race result will be out in Dec, which if the results are as good as the others, will be used on their FDA application. Thus, a year later T2 would face competition from a more useful test, which would be especially troublesome if CNA succeeds with the additional bacterial and fungal as well as gram + and - differentiators before symptoms show up. Can T2 do either of these additional 2? Some patients could be cured before symptoms show up. https://cnadiagnostics.com/cna-rapid-sepsis-dx/